← Back to category

Herbs vs Hepatitis

Folder: herbshepatitis
Original: Open article
Confidence
0.90
Practicability
0.90
Evidence
0.50
Fringe Score
0.20
Risk
0.20
TRL
6

Goal

Treat and prevent hepatitis and support liver health

Problem

Hepatitis (viral and toxic liver injury)

Concept Summary

A collection of traditional herbal remedies (milk thistle, dandelion, artichoke, schizandra, reishi mushroom, phyllanthus, licorice, etc.) that are claimed to protect liver cells, enhance protein synthesis, act as antioxidants, antiviral agents, and improve liver function through various phytochemical constituents.

Principles

  • Hepatoprotective membrane stabilization
  • Antioxidant activity
  • Protein synthesis enhancement
  • Antiviral activity
  • Choleretic and cholagogue effects
  • Diuretic and laxative actions
  • Immunomodulation
  • Anti-inflammatory action

Scientific Domains

Pharmacology Botany Medicine Toxicology

Materials

  • Silybum marianum (milk thistle)
  • Taraxacum officinale (dandelion)
  • Cynara scolymus (artichoke)
  • Schisandra sinensis (schizandra)
  • Ganoderma lucidum (reishi mushroom)
  • Phyllanthus spp.
  • Glycyrrhiza glabra (licorice)
  • Salvia miltiorrhiza (salvia)

Mechanisms of Action

  • Stabilisation of hepatocyte membranes against toxins
  • Scavenging of free radicals
  • Stimulation of liver protein synthesis
  • Inhibition of viral replication
  • Promotion of bile flow
  • Diuretic removal of waste metabolites
  • Modulation of immune response

Applications

  • Treatment of hepatitis B and other viral hepatitis
  • Support of liver function in chronic liver disease
  • Adjunct therapy for detoxification and liver protection

Claimed Performance

Protection against carbon tetrachloride, ethanol, and mushroom toxins; reduction of liver enzymes in hepatitis patients; clinical cure in 65 % of cases with schizandra; >70 % effective rate for licorice in chronic hepatitis B; symptom improvement and reduced fatigue in reishi trials.

Experimental Evidence

Several in-vitro, animal, and limited human clinical studies are cited, including randomized open studies of silymarin, animal protection studies with schizandra, and clinical trials of licorice and reishi mushroom showing symptom improvement.

Replication Status

Clinical trials and animal studies reported; no large-scale commercial deployment.

Limitations

  • Variability in herb composition and potency
  • Limited large-scale randomized controlled trials
  • Potential side effects (e.g., licorice-induced hypertension)
  • Lack of standardized dosing guidelines

Red Flags

  • Reliance on anecdotal and small-scale studies
  • Potential for herb-drug interactions
  • Risk of adulterated or contaminated herbal material

Keywords

hepatitis herbal medicine silymarin hepatoprotective antiviral liver health traditional Chinese medicine

Related Technologies

Standardized herbal extracts Conventional antiviral drugs (e.g., interferon) Liver function testing kits

📷 Images

0logo.gif
0logo.gif